[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%",
    "summary": "Key Insights Significantly high institutional ownership implies Bristol-Myers Squibb's stock price is sensitive to...",
    "url": "https://finnhub.io/api/news?id=f25a31d0e1037f9de49053955a8cf39d428163a4e5525fc9a1ff028b86255773",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734868828,
      "headline": "Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%",
      "id": 132109885,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/61ae5b4abdbb9c040fe4f1989e525046",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Key Insights Significantly high institutional ownership implies Bristol-Myers Squibb's stock price is sensitive to...",
      "url": "https://finnhub.io/api/news?id=f25a31d0e1037f9de49053955a8cf39d428163a4e5525fc9a1ff028b86255773"
    }
  },
  {
    "ts": null,
    "headline": "Prothena Surges After Parkinson's Drug Misses Primary Endpoint",
    "summary": "Prothena's stock soared 34% despite setbacks, with promising partnerships and potential in Parkinson's and Alzheimer's diseases. Explore more here.",
    "url": "https://finnhub.io/api/news?id=ec3bb3287facb70164809f9fa4e2b22aacfcf664bc2f074af44f61f1cf11716a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734861600,
      "headline": "Prothena Surges After Parkinson's Drug Misses Primary Endpoint",
      "id": 132109764,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1945032265/image_1945032265.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Prothena's stock soared 34% despite setbacks, with promising partnerships and potential in Parkinson's and Alzheimer's diseases. Explore more here.",
      "url": "https://finnhub.io/api/news?id=ec3bb3287facb70164809f9fa4e2b22aacfcf664bc2f074af44f61f1cf11716a"
    }
  }
]